Through this announcement, OMH seeks to develop Hepatitis B model programs that will end transmission of HBV (perinatal, children and adults) and reduce morbidity and mortality attributable to ongoing HBV infection.
Service delivery efforts will focus on delivery of prompt, responsive and efficient
care for persons born in countries where HBV infection is endemic; U.S.-born persons not vaccinated as infants whose parents were born in countries with a very high prevalence of HBV infection; household contacts or sexual partners of persons with HBV infection; and infants/children/adolescents who may otherwise slip through the cracks and improve reach of services essential to eliminating hepatitis B.
OMH will fund collaborative partnerships to build capacity for scale-up HBV vaccination, testing and linkage to care services and surveillance to advance progress toward national hepatitis B elimination goals recommended by the National Academies of Sciences (NAS).
Successful applicants and their collaborative partnerships will implement all of the community-level strategies outlined below.